Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Information source: Virginia Commonwealth University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Shock, Hemorrhagic
Intervention: Plasma (Biological); Normal saline (Drug)
Phase: Phase 2/Phase 3
Status: Recruiting
Sponsored by: Virginia Commonwealth University Official(s) and/or principal investigator(s): Bruce D Spiess, MD, FAHA, Principal Investigator, Affiliation: VCU
Overall contact: Mary J Michael, RN, MS, Phone: 804-628-3247, Email: mmichael@mcvh-vcu.edu
Summary
Type A Thawed Plasma (TP) will be compared in polytrauma patients who receive only Normal
Saline (NS) (standard of care) before arrival at the hospital.
The purpose of this study is to determine if prehospital administration of thawed plasma can
reduce mortality of patients who have lost a large amount of blood due to their injuries,
compared to those receiving standard of care.
Clinical Details
Official title: Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Mortality
Secondary outcome: Coagulation function (thromboelastography, RoTEM, Hemodyne, fibrinogen, D-dimer, PFA-100, platelet count, flow cytometry)Vital signs (blood pressure, pulse, temperature) Blood product utilization (number of red blood cell units, number of plasma units, number of platelet units cryoprecipitate doses) Lipidomic profiles (arachidonic acid, eicosinoid expression, prostacyclin expression) Blood biochemistry (pH, bicarbonate, lactate) Hematology (Hemoglobin, hematocrit) Hospital outcomes (number of cases of multi-system organ failure (MSOF), renal failure, length of hospital stay, length of ICU stay, number of days on a ventilator, number of surgeries, number of infections)
Detailed description:
INVESTIGATIONAL PLAN This will be an open-label, non-blinded, randomized clinical trial to
investigate mortality (30 days) and morbidity of Type A thawed Plasma (TP) versus NS
infusion at earliest contact, administered by Emergency Medical Service (EMS) supervisors to
subjects who have sustained severe Polytrauma / Major hemorrhage (PTr / MH). The total study
is expected to last 2 years with 210 patients enrolled.
The two EMS agencies involved in the study will each have one EMS supervisor quick-response
vehicle (QRV) equipped with an approved, validated refrigeration unit for TP transport. EMS
personnel trained in plasma administration and recognition of reactions may administer up to
2 units of TP to subjects approved for study enrollment. Blood samples for coagulation and
lipid testing will be drawn prior to TP administration by EMS personnel,and repeated by
hospital personnel at 30 minutes, 8 hours, and 24 hours post-injury.
This study is approved for "Exception from Informed Consent" (EFIC). Once the patient has
reached VCUMC and has been entered into the VCUMC health care system, the treating team will
advise the Study Coordinator (SC) whether or not a subject is able to consent. As the
plasma administration will occur in the field prior to arrival to VCUMC, the SC will make
every effort possible to obtain consent from the subject or legally authorized
representative (LAR) for continued study participation before the next intervention (8 hour
blood specimen collection). The attempts to contact the LAR will be documented in detail.
If a subject lacks the ability to provide his/her own consent by the end of day 30, the
consent signed by the LAR will be the consent document in force at the subject's completion
of the study and no further consent will be sought.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Blunt or penetrating trauma,
- Blood Pressure (BP) systolic <70 mmHg or BP 70-90 mmHg with Heart Rate (HR) > 108
Beats Per Minute (BPM),
- Ongoing hemorrhage with unstable vital signs
Exclusion Criteria:
- Wearing opt-out wrist band,
- Wearing medical alert jewelry / bracelet, etc. indicating Jehovah Witness or similar
with objections to blood transfusions,
- Refusal to participate (by subject or LAR),
- Communication barrier at the time of eliciting refusal (non-English speaking or
non-Spanish speaking),
- Not expected to survive transport to Virginia Commonwealth University Medical Center
(VCUMC),
- Documented Do Not Resuscitate (DNR) order found,
- Cardiac arrest or Cardio-Pulmonary Resuscitation (CPR) prior to randomization
- Penetrating head trauma,
- Known / obvious pregnancy,
- Prisoner,
- Burns > 20% of body surface
Locations and Contacts
Mary J Michael, RN, MS, Phone: 804-628-3247, Email: mmichael@mcvh-vcu.edu
Virginia Commonwealth University, Richmond, Virginia 23298, United States; Recruiting
Additional Information
Starting date: November 2014
Last updated: April 27, 2015
|